首页> 外文会议>International Conference on Materials Science and Application >Cross-linking Peptide Vaccine Heat Shock Protein 72 and Alpha-fetoprotein Elicited Specific Dendritic Cells, Cytotoxic T-lymphocyte Cells and Natural Killing Cells
【24h】

Cross-linking Peptide Vaccine Heat Shock Protein 72 and Alpha-fetoprotein Elicited Specific Dendritic Cells, Cytotoxic T-lymphocyte Cells and Natural Killing Cells

机译:交联肽疫苗热休克蛋白72和α-胎蛋白引发特异性树突细胞,细胞毒性T淋巴细胞细胞和天然杀伤细胞

获取原文

摘要

Alpha-fetoprotein (AFP) is an oncofetal protein during Hepatocellular carcinoma (HCC) development which could generate weaker and less reproducible antitumor protection, and may serve as a target for immunotherapy. Therefore, it is imperative to enhance its immunogenicity and develop therapeutic vaccines to eliminate AFP-expressing tumors. In this study, by way of peptide synthesis method, we constructed a potential therapeutic peptide vaccine, heat shock protein 72 (HSP72) and AFP peptide containing the specific antigen epitope. Our results demonstrated that AFP peptide and HSP72 synergistically exhibited significant increases in AFP-specific dendritic cells, CD8~+ T cells, natural killing cells responses and impressive antitumor effects against AFP-expressing tumors. Our study suggests that a tumor peptide vaccine by cross-linking AFP peptide and HSP72 peptide is a promising approach for HCC therapy.
机译:α-胎蛋白(AFP)是肝细胞癌(HCC)开发期间的血管蛋白蛋白,其可能产生较弱和更可重复的抗肿瘤保护,并且可以作为免疫疗法的靶标。因此,它必须增强其免疫原性并开发治疗疫苗以消除表达AFP的肿瘤。在该研究中,通过肽合成方法,我们构建了潜在的治疗性肽疫苗,热休克蛋白72(HSP72)和含有特异性抗原表位的AFP肽。我们的研究结果表明,AFP肽和HSP72协同效应地表现出AFP特异性树突细胞,CD8〜+ T细胞,天然杀死细胞应答和对AFP表达肿瘤的令人印象深刻的抗肿瘤作用。我们的研究表明,通过交联AFP肽和HSP72肽的肿瘤肽疫苗是HCC疗法的有希望的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号